Future prospects for an Innovative Medicines Fund for EnglandOn the 12 December 2019, the UK general public voted for a further five years of Conservative government. Share XFuture prospects for an Innovative Medicines Fund for Englandhttps://pharmaphorum.com/views-analysis-market-access/future-prospects-for-an-innovative-medicines-fund-for-england/
NHS pressures are threatening vital research, says reportMedical research that could have a direct impact on patient care is being blocked by the workload piled Share XNHS pressures are threatening vital research, says reporthttps://pharmaphorum.com/news/nhs-pressures-are-threatening-vital-research-says-report/
Critics says government contract gifts NHS data to AmazonA deal signed in the summer between the UK government and Amazon has been criticised after it emerged Share XCritics says government contract gifts NHS data to Amazonhttps://pharmaphorum.com/news/critics-slam-deal-to-gift-nhs-data-to-amazon/
Don’t use NHS as “political weapon” in election campaign, managers sayThe state of the National Health Service is always a major issue come election time, and the run-up Share XDon’t use NHS as “political weapon” in election campaign, managers sayhttps://pharmaphorum.com/news/dont-use-nhs-as-political-weapon-in-election-campaign-managers-say/
Biosimilars in the UK: where are we now and where does the NHS want to go?The UK health service has well over a decade’s experience of dealing with biosimilars, but the NHS acknowledges Share XBiosimilars in the UK: where are we now and where does the NHS want to go?https://pharmaphorum.com/views-analysis-market-access/biosimilars-in-the-uk/
Scotland says ‘yes’ to Gilead’s CAR-T Yescarta for lymphomaThe Scottish Medicines Consortium has backed NHS funding for Gilead’s CAR-T therapy Yescarta for B-cell lymphomas, a few Share XScotland says ‘yes’ to Gilead’s CAR-T Yescarta for lymphomahttps://pharmaphorum.com/news/scotland-says-yes-to-gileads-car-t-yescarta-for-lymphoma/
From supplier to partner – how industry can work better with the new-look NHSA move towards integrated care systems (ICS), complete with new primary care roles, and a greater focus on Share XFrom supplier to partner – how industry can work better with the new-look NHShttps://pharmaphorum.com/views-analysis-market-access/from-supplier-to-partner-how-industry-can-work-better-with-the-new-look-nhs/
What HCPs think about online consultationNew research suggests that HCPs are in favour of video consultations, but GPs are cautious. NHS England has Share XWhat HCPs think about online consultationhttps://pharmaphorum.com/views-analysis-digital/what-hcps-think-about-online-consultation/
Messaging app could save NHS £44 million annually, says studyAn app-based clinical messaging tool created by NHS doctors could save the NHS £44 million a year, according Share XMessaging app could save NHS £44 million annually, says studyhttps://pharmaphorum.com/news/messaging-app-could-save-nhs-44-million-annually-says-study/
